MedPath

INSTITUTE OF LIVER AND BILIARY SCIENCES

INSTITUTE OF LIVER AND BILIARY SCIENCES logo
🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotide Analogue Therapy.

Not Applicable
Conditions
Hepatitis B
Interventions
First Posted Date
2017-04-21
Last Posted Date
2020-02-05
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
118
Registration Number
NCT03123653
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

Recombinant Human Granulocyte Monocyte - Colony Stimulating Factor (GM CSF) for Prevention of Pneumonia in Patients With Cirrhosis

Not Applicable
Conditions
Cirrhosis
Interventions
Drug: GMCSF
Other: Placebo
First Posted Date
2017-04-21
Last Posted Date
2020-02-20
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
160
Registration Number
NCT03123666
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue

Phase 4
Completed
Conditions
Vasoplegia
Septic Shock
Cirrhosis, Liver
Refractory Shock
Interventions
First Posted Date
2017-04-19
Last Posted Date
2018-01-30
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
111
Registration Number
NCT03120637
Locations
🇮🇳

Liver Coma ICU, Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

High Volume Plasmapheresis for Refractory Hepatic Encephalopathy in Liver Intensive Care Unit.

Not Applicable
Withdrawn
Conditions
Refractory Hepatic Encephalopathy
Interventions
Biological: Plasmapheresis
First Posted Date
2017-04-14
Last Posted Date
2019-11-04
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Registration Number
NCT03115697
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

A Comparison of Fecal Microbiota Transplantation and Steroid Therapy in Patients With Severe Alcoholic Hepatitis.

Not Applicable
Conditions
Severe Alcoholic Hepatitis
Interventions
Other: Fecal Microbiota Transplantation
Drug: Steroids
First Posted Date
2017-03-27
Last Posted Date
2020-01-22
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
112
Registration Number
NCT03091010
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C Cirrhosis

Not Applicable
Conditions
Cirrhosis
Interventions
Procedure: Endoscopic Variceal Ligation
First Posted Date
2017-03-03
Last Posted Date
2020-02-19
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
330
Registration Number
NCT03069339
Locations
🇮🇳

Institute of liver and Biliary Sciences, New Delhi, Delhi, India

Antegrade Arterial and Portal Flushing Versus Portal Flushing Only in LDLT

Phase 4
Completed
Conditions
Graft Function, Delayed
Biliary Complications
Interventions
Procedure: Arterial Flushing
Procedure: Portal Flushing
First Posted Date
2017-02-09
Last Posted Date
2017-06-29
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
85
Registration Number
NCT03048318

Impact of Acute Decompensation in Patients of Cirrhosis With or Without Prior Decompensation

Withdrawn
Conditions
Acute Decompensation in Liver Cirrhosis
First Posted Date
2016-12-29
Last Posted Date
2018-06-26
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Registration Number
NCT03005587
Locations
🇮🇳

Institute of Liver and Biliary Sciences., New Delhi, Delhi, India

On Demand Versus Protocol-guided Renal Replacement Therapy for Management of Stage 3 Acute Kidney Injury in Patients With Cirrhosis

Not Applicable
Conditions
Acute Kidney Injury With Cirrhosis
Interventions
Biological: Protocol Guided Renal Replacement Therapy
Biological: On Demand Renal Replacement Therapy
First Posted Date
2016-10-19
Last Posted Date
2017-11-29
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
2
Registration Number
NCT02937935
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

Early Versus Late Sustained Low Efficiency Dialysis in Critically Ill Cirrhotics With Septic Shock and Acute Kidney Injury

Not Applicable
Conditions
Cirrhotics With Septic Shock and Acute Kidney Injury
Interventions
Biological: Late SLED
Biological: Early SLED
First Posted Date
2016-10-19
Last Posted Date
2019-03-07
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
150
Registration Number
NCT02937961
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

© Copyright 2025. All Rights Reserved by MedPath